Bibliotecas PUC-SP - Busca Integrada

MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process

Por Chantal Lechanteur, Alexandra Briquet, Virginie Bettonville, Etienne Baudoux, Yves Beguin
Publicado no Cells (2021-05-01)

Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B ly...

Por Alexandra Briquet, Sophie Dubois, Sandrine Bekaert, Marie Dolhet, Yves Beguin, André Gothot
Publicado no Haematologica (2010-01-01)

Imatinib and nilotinib inhibit hematopoietic progenitor cell growth, but do not prevent adhesion, migration and engraftment of human cord blood CD34+ cells.

Por Ludovic Belle, France Bruck, Jacques Foguenne, André Gothot, Yves Beguin, Frédéric Baron, Alexandra Briquet
Publicado no PLoS ONE (2012-01-01)

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury

Por Pascal Rowart, Pauline Erpicum, Olivier Detry, Laurent Weekers, Céline Grégoire, Chantal Lechanteur, Alexandra Briquet, Yves Beguin, Jean-Marie Krzesinski, François Jouret
Publicado no Journal of Immunology Research (2015-01-01)

Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation.

Por Marilène Binsfeld, Yves Beguin, Ludovic Belle, Eléonore Otjacques, Muriel Hannon, Alexandra Briquet, Roy Heusschen, Pierre Drion, Jenny Zilberberg, Bjarne Bogen, Frédéric Baron, Jo Caers
Publicado no PLoS ONE (2014-01-01)

Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioni...

Por Gérôme Lombardo, Chantal Lechanteur, Alexandra Briquet, Laurence Seidel, Evelyne Willems, Sophie Servais, Etienne Baudoux, Tessa Kerre, Pierre Zachee, Julie Herman, Audrey Janssen, Joséphine Muller, Frédéric Baron, Yves Beguin
Publicado no Stem Cell Research & Therapy (2024-12-01)

Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial

Por Céline Grégoire, Céline Grégoire, Nathalie Layios, Nathalie Layios, Bernard Lambermont, Bernard Lambermont, Chantal Lechanteur, Alexandra Briquet, Virginie Bettonville, Etienne Baudoux, Marie Thys, Nadia Dardenne, Benoît Misset, Yves Beguin, Yves Beguin, Yves Beguin
Publicado no Frontiers in Immunology (2022-07-01)

Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis

Por Sophie Servais, Frédéric Baron, Chantal Lechanteur, Laurence Seidel, Etienne Baudoux, Alexandra Briquet, Dominik Selleslag, Johan Maertens, Xavier Poire, Wilfried Schroyens, Carlos Graux, Ann De Becker, Pierre Zachee, Aurélie Ory, Julie Herman, Tessa Kerre, Yves Beguin
Publicado no Frontiers in Immunology (2023-02-01)

Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model

Por Céline Grégoire, Céline Grégoire, Caroline Ritacco, Muriel Hannon, Laurence Seidel, Loïc Delens, Ludovic Belle, Sophie Dubois, Sophie Vériter, Chantal Lechanteur, Alexandra Briquet, Sophie Servais, Sophie Servais, Gregory Ehx, Yves Beguin, Yves Beguin, Yves Beguin, Frédéric Baron, Frédéric Baron
Publicado no Frontiers in Immunology (2019-04-01)